论文部分内容阅读
那他珠单抗(商品名TYSABRI)是一种怎样的药物?那他珠单抗制剂的活性成分是那他珠单抗,每4周静脉滴注1次用于治疗复发-好转型多发性硬化(multiple sclerosis,MS),这种类型的MS临床上表现为疾病复发期与好转期交替出现。那他珠单抗在单独使用β干扰素(治疗MS的药物)疗效不佳时或疾病严重恶化时使用。那他珠单抗由欧洲委员会于2006年6月批准在欧盟国家上市。
What kind of drug is natalizumab (trade name TYSABRI)? The active ingredient of natalizumab is natalizumab, which is given intravenously once every four weeks for the treatment of relapsed-and-prone, multiple-onset In multiple sclerosis (MS), this type of MS is clinically manifested as a recurrence of the disease alternating with a turn-around. Natalizumab is used when the efficacy of interferon beta alone (the drug used to treat MS) is poor or the disease worsens. Natalizumab was approved by the European Commission in June 2006 for listing in EU countries.